Showing 1301-1310 of 4117 results for "".
Inflammatory Responses: Managing Psoriasis in Light of Comorbidities
https://practicaldermatology.com/topics/psoriasis/inflammatory-responses-managing-psoriasis-in-light-of-comorbidities/20440/The accumulated evidence suggests that dermatologists must take an active role in addressing risks.Technology Solutions: Q&A With Nextech's Dr. Jason Handza
https://practicaldermatology.com/topics/practice-management/technology-solutions-q-nextechs-dr-jason-handza/28649/Nextech this year introduced Nextech RCM Professional Billing Services, an addition to their practice management software suite. This solution simplifies insurance billing complexities, helping practices reduce administrative burdens and enhance financial performance through optimized cash flow.Lose Your Inhibitions: Expanding Use of JAK Inhibitors
https://practicaldermatology.com/topics/atopic-dermatitis/lose-your-inhibitions-expanding-use-of-jak-inhibitors/23910/Despite data on safety concerns, dermatologists and patients see benefits.Jejunal Trichobezoar in a 3-year-old Boy; Practice Path MD Pro Tip: Architects
https://practicaldermatology.com/youngmd-connect/resident-resource-center/jejunal-trichobezoar-in-a-3-year-old-boy-practice-path-md-pro-tip-architects/20697/Biologic Therapies for 2013: Do We Use Them Enough?
https://practicaldermatology.com/topics/psoriasis/biologic-therapies-for-2013-do-we-use-them-enough/22931/Herbals in the Holistic Treatment of Psoriasis: An Update
https://practicaldermatology.com/topics/psoriasis/herbals-in-the-holistic-treatment-of-psoriasis-an-update/23716/As interest in herbals increases, dermatologists should be aware of commonly used agents.Cutaneous Manifestations Associated with Nemolizumab
https://practicaldermatology.com/issues/september-2025/cutaneous-manifestations-associated-with-nemolizumab/37628/In the 2025 study by Sasaki et al entitled “Clinical characteristics and risk factors for cutaneous manifestations associated with nemolizumab in atopic dermatitis: a multicenter retrospective study in Japan,” nemolizumab-induced cutaneous eruptions were found to be relatively common, typically occuBiologics for Psoriasis and the Impact of the COVID-19 Pandemic
https://practicaldermatology.com/topics/psoriasis/biologics-for-psoriasis-and-the-impact-of-the-covid-19-pandemic/23553/A real-world look at how COVID-19 impacted patient care.Histiocytoses: A Review of the Most Recent Classification System
https://practicaldermatology.com/topics/skin-cancer-photoprotection/histiocytoses-a-review-of-the-most-recent-classification-system/20503/A look at the proposed new classification system, grouping the histiocytoses into five categories, with tabular summaries for differential diagnosis.Tips for Management of Cutaneous Squamous Cell Carcinoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/tips-for-management-of-cutaneous-squamous-cell-carcinoma/57254/Cutaneous squamous cell carcinoma (cSCC) is one of the most common malignancies encountered in dermatologic practice. Current treatment guidelines for cSCC provide recommendations based largely on tumor risk classification, while emphasizing the importance of clinical judgment and patient-specific f